ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,000 | 0.0% | 110 | +29.4% | 0.00% | – |
| Q2 2015 | $4,000 | -98.3% | 85 | -97.7% | 0.00% | -100.0% |
| Q1 2015 | $234,000 | -6.8% | 3,685 | -9.8% | 0.00% | 0.0% |
| Q4 2014 | $251,000 | +58.9% | 4,085 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $158,000 | -40.4% | 4,085 | -47.0% | 0.00% | -50.0% |
| Q2 2014 | $265,000 | +71.0% | 7,708 | +113.6% | 0.00% | +100.0% |
| Q1 2014 | $155,000 | +22.0% | 3,608 | +12.5% | 0.00% | 0.0% |
| Q4 2013 | $127,000 | +21.0% | 3,208 | +14.6% | 0.00% | 0.0% |
| Q3 2013 | $105,000 | +38.2% | 2,800 | -2.1% | 0.00% | 0.0% |
| Q2 2013 | $76,000 | – | 2,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |